共 50 条
- [41] Correction: Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism Endocrine, 2022, 75 : 312 - 312
- [43] Effects of raloxifene (RLX). Alendronate (ALN) and RLX plus ALN on bone mineral density (BMD) and biochemical markers of bone turnover in postmenopausal women with osteoporosis. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S176 - S176